BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsuda K, Yamanaka K, Kondo M, Matsubara K, Sasaki R, Tomimoto H, Gabazza EC, Mizutani H. Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity. PLoS One 2012;7:e51819. [PMID: 23251632 DOI: 10.1371/journal.pone.0051819] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nakayama C, Fujita Y, Watanabe M, Shimizu H. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab. J Dermatol 2015;42:996-8. [DOI: 10.1111/1346-8138.12943] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
2 Yang W, Guo Y, Liu M, Chen X, Xiao X, Wang S, Gong P, Ma Y, Chen F. Structure and function of blueberry anthocyanins: A review of recent advances. Journal of Functional Foods 2022;88:104864. [DOI: 10.1016/j.jff.2021.104864] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Frank B, Guo H, Lebrec H, Wang X. Application of a newly-developed cynomolgus macaque BiTE-mediated cytotoxic T-lymphocyte activity assay to various immunomodulatory agents in vitro. J Immunotoxicol 2021;18:154-62. [PMID: 34714999 DOI: 10.1080/1547691X.2021.1992687] [Reference Citation Analysis]
4 Mavropoulos A, Rigopoulou EI, Liaskos C, Bogdanos DP, Sakkas LI. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol 2013;2013:569751. [PMID: 24151518 DOI: 10.1155/2013/569751] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
5 Mir Viladrich I, Daudén Tello E, Solano-López G, López Longo FJ, Taxonera Samso C, Sánchez Martínez P, Martínez Lacasa X, García Gasalla M, Dorca Sargatal J, Arias-Guillén M, García García JM. Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment. Arch Bronconeumol 2016;52:36-45. [PMID: 26187708 DOI: 10.1016/j.arbres.2015.04.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
6 Rodríguez-jiménez P, Mir-viladrich I, Chicharro P, Solano-lópez G, López-longo F, Taxonera C, Sánchez-martínez P, Martínez-lacasa X, García-gasalla M, Dorca J, Arias-guillén M, García-garcía J, Dauden E. Consenso multidisciplinar sobre prevención y tratamiento de la tuberculosis en pacientes candidatos a tratamiento biológico. Adaptación al paciente dermatológico. Actas Dermo-Sifiliográficas 2018;109:584-601. [DOI: 10.1016/j.ad.2018.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Yamanaka K, Umezawa Y, Yamagiwa A, Saeki H, Kondo M, Gabazza EC, Nakagawa H, Mizutani H. Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils. J Dermatol 2014;41:679-85. [PMID: 25099154 DOI: 10.1111/1346-8138.12560] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
8 Tan WS, Kelly S, Pitzalis C. Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis. Expert Rev Clin Immunol 2017;13:207-22. [PMID: 27690678 DOI: 10.1080/1744666X.2017.1241710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Wu M, Zhao M, Wu H, Lu Q. Immune repertoire: Revealing the "real-time" adaptive immune response in autoimmune diseases. Autoimmunity 2021;54:61-75. [PMID: 33650440 DOI: 10.1080/08916934.2021.1887149] [Reference Citation Analysis]
10 Zielinski C. Regulation von pro- und antiinflammatorischen Th17-Zellen. Z Rheumatol 2013;72:457-61. [DOI: 10.1007/s00393-012-1129-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]